Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020

The global medical devices (MD) market represents a steady growing industrial sector as well as an attractive investment opportunity for profitable rewards. However, the potential for greater investment return may be constrained by a number of barriers and risks in global medical device market — most notably, maturing industry growth stage, challenging and changing regulatory laws and procedures, and declining profit margins. Hence, in-depth information and enhanced strategic intelligence are needed to minimize the potential risks associated with new entrants into the global medical device industry.
This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (arising from the surrounding environments) in global medical devices industry and market. The major internal risks recognized in this industry include industry growth stage, industry competition pressure, market entry barriers, industry volatility, and technology challenge. The major external risks include factors like profit decline, regulation force, effect of foreign direct investment, and other risks (namely shortage of upstream supply, competition from substitutes, and purchase potential decrease).
The risk evaluation and threat rating concentrate on worldwide medical device market under the industry conditions and environments in 2014. Forecasts and projections have been performed for the trend of industry risk over the next six years (2014-2020). All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). These in-depth appraisals and analysis about risk considerations & controls provide a comprehensive understanding of the current risk factors and likelihood of risk development trends. Moreover, this report also provides wise risk management strategies and concludes Critical Success Factors (CSFs) to help identify fresh growth point and overcome the threats and obstacles of doing manufacture/business in global medical device industry.
Key Players:
Johnson & Johnson
GE Healthcare
Medtronic Inc.
Siemens AG
Baxter International Inc.
Fresenius Medical Care AG & Co. KGAA
Koninklijke Philips NV
Cardinal Health Inc.
Novartis AG
Covidien plc
Stryker Corp.
Becton, Dickinson and Co.
Boston Scientific Corp.
Essilor International SA
Allergan Inc.
St. Jude Medical Inc.
3M Co.
Abbott Laboratories
Zimmer Holdings Inc.
Terumo Corp.

CHAPTER I. INTRODUCTION
I-1. Report Scope
I-2. Evaluation Methodology
I-3. Executive Summary
CHAPTER II. INTERNAL RISK
II-1. Overview of Internal Risk 2014-2020
II-2. Industry Growth Stage 2014-2020
II-3. Industry Competition Pressure 2014-2020
II-4. Market Entry Barriers 2014-2020
II-5. Industry Volatility 2014-2020
II-6. Technology Challenge 2014-2020
CHAPTER III. EXTERNAL RISK
III-1. Overview of External Risk 2014-2020
III-2. Profit Decline 2014-2020
III-3. Regulation Force 2014-2020
III-4. Foreign Direct Investment (FDI) 2014-2020
III-5. Other Risks 2014-2020
CHAPTER IV. SUMMARY AND FORCAST
IV-1. Summary of Medical Device Industry Risk in 2014
IV-2. Forecast of Medical Device Industry Risk to 2020
CHAPTER V. CRITICAL SUCCESS FACTORS (CSFs)
CHAPTER VI. RELATED REPORTS

Johnson & Johnson
GE Healthcare
Medtronic Inc.
Siemens AG
Baxter International Inc.
Fresenius Medical Care AG & Co. KGAA
Koninklijke Philips NV
Cardinal Health Inc.
Novartis AG
Covidien plc
Stryker Corp.
Becton, Dickinson and Co.
Boston Scientific Corp.
Essilor International SA
Allergan Inc.
St. Jude Medical Inc.
3M Co.
Abbott Laboratories
Zimmer Holdings Inc.
Terumo Corp.
Table 1. List of Risk Factors and Weight Percentages
Table 2. Definition of GMD Risk Index Number (RIN) and GMD Risk Intensity Level (RIL)
Table 3. Overall Risk Index Numbers of Global Medical Device Industry 2014-2020
Table 4. Overview of Internal Risk 2014-2020
Table 5. Quarterly IPO Count and Value in Worldwide Medical Device Sector 2013Q1-2014Q2
Table 6. Count and Value of Venture Capital Investment (VCI) in Worldwide Medical Device Sector 2009-2014H1
Table 7. Top 30 Global MD Manufacturers Based on 2012 Revenue
Table 8. Top 40 Medical Device Producers Based on Annual Revenue in 2014
Table 9. Medical Device Exports of Leading Sourcing Countries 2012-2020 ($ bn)
Table 10. Slowdown of Global Medical Device Industry 2009-2020 ($ bn)
Table 11. Relative Innovation Level of Medtech by Country 2014
Table 12. Leading Companies in Medical Device R&D Spend by 2020
Table 13. Overview of External Risk 2014-2020
Table 14. Top Source Markets for FDI in Medical Device Sector, 2003-Jan 2014
Table 15. Top Destination Markets for FDI in MD Sector, 2003-Jan 2014
Table 16. Top Ten Investing Companies in MD Sector, 2003-Jan 2014
Table 17. Per Capita Total Expenditure on Health at Average Exchange Rate by Country 2003-2012 (US$)
Table 18. Summary of Risk Evaluation in 2014
Table 19. Summary of Risk Outlook in 2020
Table 20. List of Critical Success Factors
Figure 1. GMD RIN of Internal Risk Factors in 2014 on Radar Chart
Figure 2. GMD RIN of Industry Growth Stage in 2014 and 2020
Figure 3. GMD RIN of Industry Competition Pressure 2014 and 2020
Figure 4. GMD RIN of Market Entry Barriers in 2014 and 2020
Figure 5. GMD RIN of Industry Volatility in 2014 and 2020
Figure 6. GMD RIN of Technology Challenge in 2014 and 2020
Figure 7. Global R&D Spend in Medical Devices 2004-2020
Figure 8. GMD RIN of External Risk Factors in 2014 on Radar Chart
Figure 9. GMD RIN of Profit Decline 2014 and 2020
Figure 10. GMD RIN of Regulation Force in 2014 and 2020
Figure 11. Maximum Approval Time of Medical Devices in Various Major Markets in 2014
Figure 12. GMD RIN of Foreign Direct Investment 2014-2020
Figure 13. Total Value and Number of Global FDI Projects in Medical Device Sector 2004-2014
Figure 14. Global Share of Inward FDI into the Medical Devices Sector by Subsectors, 2003-Jan 2014
Figure 15. Global Share of Inward FDI into the MD by Business Activity, 2003-JAN 2014
Figure 16. GMD RIN of Other Risks in 2014 and 2020
Figure 17. Total Health Expenditure as a Percentage of GDP for Major Economies (2013)
Figure 18. Comparison of Risk Factors by Weighted RIN in 2014
Figure 19. Comparison of Risk Factors by Predicted Weighted RIN in 2020

Frequently Asked Questions About This Report

Choose License Type

Single user
$1,800
Multi User
$2,600
Enterprise User
$3,500
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.